Evidence map›Paper›PMID 22496930›Full record

ArticleSelf/nonself2011

Cleavage of PGRP-LC receptor in the Drosophila IMD pathway in response to live bacterial infection in S2 cells.

Rebecca L Schmidt, Francesca M Rinaldo, Shayla E Hesse, Masakazu Hamada, Zachary Ortiz, Daniah T Beleford, Andrea Page-McCaw, Jeffrey L Platt, Amy H Tang

Open access · hybridAbstract read
In one paragraph

Article in Self/nonself, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Rebecca L SchmidtDepartment of Biochemistry and Molecular Biology; Mayo Clinic Cancer Center; Mayo Clinic College of Medicine; Rochester, MN USA.
Francesca M Rinaldo
Shayla E Hesse
Masakazu Hamada
Zachary Ortiz
Daniah T Beleford
Andrea Page-McCaw
Jeffrey L Platt
Amy H Tang
WinnMed · USMayo Clinic · USUniversity of Michigan–Ann Arbor · USVanderbilt University Medical Center · US

Funding

Matrix metalloproteinases in Drosophila wound healingR01GM073883 · NIGMS · VANDERBILT UNIVERSITY · PI PAGE-MCCAW, ANDREA · 2006 to 2015
$2.6M
Heparan Sulfate-TLR in Health, Injury and ImmunityR01AI053733 · NIAID · MAYO CLINIC ROCHESTER · PI PLATT, JEFFREY L · 2003 to 2007
$1.6M
SIAH2-Dependent Proteolysis in Cell Migration, Tumor Growth and Cancer MetastasisR01CA140550 · NCI · EASTERN VIRGINIA MEDICAL SCHOOL · PI TANG, AMY H. · 2010 to 2014
$1.4M
Regulated Proteolysis in RAS Signal TransductionR01GM069922 · NIGMS · MAYO CLINIC ROCHESTER · PI TANG, AMY H. · 2004 to 2009
$1.3M
NCI NIH HHS R01 CA140550NIAID NIH HHS R01 AI053733NIGMS NIH HHS R01 GM069922NIGMS NIH HHS R01 GM073883
6 · The paper itself

Abstract

Drosophila responds to Gram-negative bacterial infection by activating the immune deficiency (IMD) pathway, leading to production of antimicrobial peptides (AMPs). As a receptor for the IMD pathway, peptidoglycan-recognition protein (PGRP), PGRP-LC is known to recognize and bind monomeric peptidoglycan (DAP-type PGN) through its PGRP ectodomain and in turn activate the IMD pathway. The questions remain how PGRP-LC is activated in response to pathogen infection to initiate the IMD signal transduction in Drosophila. Here we present evidence to show that proteases such as elastase and Mmp2 can also activate the IMD pathway but not the TOLL pathway. The elastase-dependent IMD activation requires the receptor PGRP-LC. Importantly, we find that live Salmonella/E. coli infection modulates PGRP-LC expression/receptor integrity and activates the IMD pathway while dead Salmonella/E. coli or protease-deficient E. coli do neither. Our results suggest an interesting possibility that Gram-negative pathogen infection may be partially monitored through the structural integrity of the receptor PGRP-LC via an infection-induced enzyme-based cleavage-mediated activation mechanism.

Identifiers

PMID22496930
PMCPMC3323661
OpenAlexW2029097882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.